CV Technologies Announces Filing of Annual Financial Statements

EDMONTON, ALBERTA--(Marketwire - Jan. 12, 2009) - CV Technologies Inc. (TSX:CVQ) CV Technologies Inc. (the "Company") announces that its annual financial statements, accompanying management's discussion and analysis, and related CEO and CFO certifications (collectively, the "2008 Annual Financial Materials") for the financial year ended September 30, 2008 have been filed on SEDAR at www.sedar.com on January 12, 2009. By these actions, the Company has cured the default of not filing the 2008 Annual Financial Materials within the 90 day prescribed period. The insiders listed in the previously announced management cease trade orders issued by the Alberta Securities Commission ("ASC") and Ontario Securities Commission ("OSC") will no longer be restricted from trading in securities of the Corporation pursuant to such orders as of January 15, 2009 in the case of the ASC order and January 21, 2009 in the case of the OSC order.

ABOUT CV TECHNOLOGIES INC.

CV Technologies, founded in 1992, strives to transform people's lives to be healthier and happier by focusing on prevention and recovery through the use of evidence-based naturally-derived health products. The Company's lead product COLD-FX^® strengthens the immune system and is widely used as a leading over the counter (OTC) remedy for helping to prevent and relieve cold and flu infections. COLD-FX continues to rank as the number one selling cold and flu remedy in Canada (ACNielsen's MarketTrack Drug Service for Cold Remedies, Natural Supplements & Vitamins Categories for the 52 week period ending September 27, 2008).

Forward Looking Information

This news release contains certain forward-looking information within the meaning of applicable securities laws. The forward-looking information included in this document does not guarantee future performance and should not be unduly relied upon. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The Company believes that the expectations and assumptions reflected in the forward-looking information contained herein are reasonable but no assurance can be given that these expectations and assumptions are correct or that any benefits may be derived from them. All forward-looking information is expressly qualified in its entirety by this cautionary statement. The Company assumes no duty to update or revise forward looking information, except as may be required pursuant to applicable laws. The Company claims exemption under SEC Rule 12g3-2(b).